| Title: | Associations of sleep duration with the incidence of severe non alcoholic fatty liver disease(NAFLD). |
| Lead Institution: | Southern Medical University |
| Principal investigator: |
Application 409444
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Non alcoholic fatty liver disease (NAFLD) which affects 25% of the population worldwide is rapidly becoming the most common cause of chronic liver disease and its prevalence is expected to increase in the near future.Obviously, NAFLD is one of the diseases that seriously affects human health, with a high incidence rate, many and complex pathogenic factors, and there is currently no approved drug treatment, and the first-line treatment for NAFLD is lifestyle modification. Therefore, it is particularly important to identify all modifiable lifestyle factors associated with the onset of NAFLD.As sleep occupies 1/3 of the human life cycle, it is of great value and significance to study its association with severe non-alcoholic fatty liver disease. At the same time, sleep problems have become the most common medical and health problems in today's society, and it is urgent to study its association with severe non-alcoholic fatty liver disease. The association between sleep duration and NAFLD was unclear.We aim to explore the associations between sleep duration and NAFLD in a large population-based cohort study. Our project will provide evidence for developing efficient strategies to reduce the morbidity of NAFLD. This project is expected to last for 36 months. The findings may deepen the understanding of associations between sleep duration and NAFLD, and may provide strong evidence for the prevention of NAFLD, and even make a significant contribution to global public health.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 15312 | Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes | Qian Wang (+10) | 2025 | Diabetes & Metabolism |
Enabling scientific discoveries that improve human health